“…To fill this gap, we studied a model homomeric Cys-loop receptor composed of the ligand binding domain from the ␣7 nicotinic receptor and pore and cytoplasmic domains from the 5-HT 3A receptor (Palma et al, 1996;Bouzat et al, 2004Bouzat et al, , 2008Rayes et al, 2005). To vary the number of agonist binding sites, we installed mutations that prevent agonist binding and, to report the presence of the mutant subunit, installed mutations that alter the single-channel conductance (Kelley et al, 2003).…”